Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04777825

Heart Rate Variability Biofeedback Training in Psychogenic Disorders

To study whether Heart Rate Variability (HRV) biofeedback training can improve abnormal head posture and painful symptomatology in patients with "cervical dystonia" not selected for DBS after extensive screening in a specialized unit but diagnosed " dysfunctional ".

Patients of the respiratory coherence group will receive HRV biofeedback training for 12 sessions during a 6 months-period. The hypothesis is that this kind of physiological noninvasive therapy increasing coherence respiratory, will reduce pain and patient's complain about their psychogenic abnormal head posture. Improvement of anxiety, depression and quality of life are expected.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Patients presenting with an isolated abnormal head posture, first diagnosed as cervical dystonia, demonstrated in fact, after neurological screening, to be of psychogenic origine. These patients are not candidate for functional surgery and, furthermore, usually refuse psychotherapy leading them to medical nomadism. This study proposes to evaluate the efficacy of an innovative intervention program based on Heart Rate Variability (HRV) biofeedback that promotes self-regulatory skills in dysfunctional movement disorders (DMD) patients in order to improve their condition and symptomatology.

Heart rate is under the control of efferent sympathetic and vagal activities directed to the sinus node, which are modulated by central brain stem (vasomotor and respiratory centers) and peripheral oscillators (oscillation in arterial pressure and respiratory movements). Spectral analysis of HRV is a reliable quantitative method for analyzing the modulatory effects of neural mechanisms on the sinus node. Several biofeedback protocols and assistive electronic technologies, such as proposed by SymbioCenter©, exist to enhance increase HRV and synchronize respiration with the heart rhythm. HRV biofeedback training appears to be an opportunity in the patient's management in order of preventing medical overconsuming. It is offering a safe and non-pharmacological alternative approach managed by a multidisciplinary team in a functional neurosurgery unit. It is expected that developing respiratory coherence in these patients will improve their painful symptomatology.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 75
  • Responding to somatoform disorder characteristics as described in ICD-10 (F45: "The onset of physical symptoms associated with an insistent medical quest, persisting despite repeated negative assessments and statements by physicians that the symptoms have no organic basis. If there is a genuine physical disorder, it does not account for the nature or severity of the symptoms, or the distress or concerns of the subject. The multidisciplinary team will determine whether or not the diagnosis of conversion disorder (disorder with functional neurological symptoms) of the DSMV (300.11) [ICD-10 equivalent: F44.4 "dissociative disorder with abnormal movements"] is associated with the diagnosis of conversion disorder (disorder with functional neurological symptoms) of the DSMV (300.11) [ICD-10 equivalent: F44.4 "dissociative disorder with abnormal movements"], selected by the multidisciplinary team after a phase 1 assessment.
  • Patient benefiting from a social security scheme

Exclusion criteria

  • Simulation identified with obvious search for secondary benefit according to the ICD-10 classification ( Z76.5 Simulator: Person pretending to be ill (with obvious motivation"), or DSM-V(V65.2)
  • Any other specific PAT-specific CEP (botulinum toxin, psychotherapy and/or relaxation provided by a professional (CBT, ACT, Mindfulness, etc.)) scheduled within 6 months, with the exception of the usual analgesics (Tier I or II)Presenting significant cognitive impairment (MoCa test ≤ 24/30),
  • Absence foreseeable at least 30% of the sessions,
  • Lack of informed consent.
  • Pregnancy or planned pregnancy during the study period, Pregnant or breastfeeding women
  • Major protected by law or patient under guardianship or curatorship
  • Participation in other ongoing research

Treatment and study plan

Heart rate variability biofeedback training (Symbiocenter)

Other

12 sessions of thirty minutes. Patients will participate through several serious game associated with HRV biofeedback training

psychoeducation session

Other

Each patient will therefore be presented individually with a Powerpoint consisting of 35 slides divided into 4 sub-sections explaining in a fun and educational format the physiological model of stress, the respiratory function and its benefits, presentation of various relaxation techniques and recommendations for reading (stress management, letting go, mindfulness meditation) and other tools to help relaxation (smartphone applications).

Primary outcomes

  1. Variability of the cervical dystonia at 6 months

    Time frame: 6 months

    Measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale. The total score is 0 (better outcome) to 85 (worse outcome)

Secondary outcomes

  1. Variability of the cervical dystonia at 3 months

    Time frame: 3 months

    Measured by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scale. The total score is 0 (better outcome) to 85 (worse outcome)

  2. Quality of life assessment in cervical dystonia at 3 months

    Time frame: 3 months

    Measured by the Craniocervical Dystonia Questionnaire (CDQ24) scale

  3. Quality of life assessment in cervical dystonia at 6 months

    Time frame: 6 months

    Measured by the Craniocervical Dystonia Questionnaire (CDQ24) scale

  4. Quality of life assessment at 3 months

    Time frame: 3 months

    Measured by SF-36 scale

  5. Quality of life assessment at 6 months

    Time frame: 6 months

    Measured by SF-36 scale

  6. Assessment of the severity of depression at 3 month

    Time frame: 3 months

    Measured by Beck Depression Inventory (BDI-II) scale

  7. Assessment of the severity of depression at 6 month

    Time frame: 6 months

    Measured by the Beck Depression Inventory (BDI-II) scale

  8. Assessment of the anxiety at 3 month

    Time frame: 3 months

    Measured by the State-Trait Anxiety Inventory (STAI A & B) scale

  9. Assessment of the anxiety at 6 month

    Time frame: 6 months

    Measured by the State-Trait Anxiety Inventory (STAI A & B) scale

  10. satisfaction with the care

    Time frame: 6 months

    satisfaction's VAS

  11. medical nomadism index

    Time frame: 6 months

    The index of "presumed nomadism" is the difference between the number of different doctors consulted and the number of different specialties of these same doctors. Any patient whose index is ≥ 3 over a period of 6 months is presumed nomadic.

Study contacts

Contact information is provided by the study sponsor or research team.

Emily SANREY, MSc

CONTACT

[email protected]

467337445 ext. +33

Valérie GIL, CTA

CONTACT

[email protected]

467337464 ext. +33

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Evaluation of the Effectiveness of a Heart Rate Variability Biofeedback Training in the Management of Dysfunctional (Somatoform) Disorders

Acronym: ECoDys

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Mar 2, 2021
Registry last updated
May 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.